Spotlight on Science: The Weight Debate — Best Practices for High-Risk Medication Dosing Controversies in Extreme Weight Patients

Broadcast Date: January 20, 2026

ABOUT THIS PODCAST

A highlight from exceptional sessions at the 2025 Midyear Clinical Meeting & Exhibition, this podcast explores dosing conundrums specific to agents in oncology chemotherapy, antimicrobials, and therapeutic heparin use in over and underweight patients. Listeners will understand the complexity given conflicting data and receive guidance for dosing considerations to implement in clinical practice

SPEAKERS

Vicki Basalyga, PharmD, BCPS, BCPPS
Director, Member Relations, ASHP
Mitchell Buckley, FASHP, FCCM, FCCP, BCCCP, BCPS
Managing Partner/Clinical Specialist, Buckley Group Enterprises

LISTEN ON

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

ASHP Pharmacy Futures 2024

Welcome to our new format!

Start Here

Drug Shortages

Your first stop for information and resources on drug products, their availability, and management

Learn More